← Back to Clinical Trials
Recruiting NCT06833567

NCT06833567 Mentalizing and Epistemic Trust in Patients With Anxiety and Depression.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06833567
Status Recruiting
Phase
Sponsor Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Condition Anxiety Disorders
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2024-04-28
Primary Completion 2026-05-29

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Brief mentalization-based group psychotherapyAcceptance and Commitment Therapy group intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2024-04-28 with a primary completion date of 2026-05-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized clinical trial aims to evaluate the effects of mentalization-based group psychotherapy in patients diagnosed with anxiety and/or depression disorders. In total 100 users of mental health communitary services will be recruited for this study. Participants will be randomized in two parallel groups: to receive usual acceptance and commitment therapy group intervention (control group) or to receive brief mentalization-based group psychotherapy (intervention group). Participants in the trial will be assessed at baseline and at 3 months.

Eligibility Criteria

Inclusion Criteria: * Participants are 18 years or older. * Participants have a diagnosis of ICD-10 F32, F33, F34, F41.1, F41.2, F43 or F43.2. * Participants have minimal relational skills to participate in group therapy. * Participants agree to be part of the study by giving signed written consent. Exclusion Criteria: * Participants have a diagnosis of ICD-10 F10-19, F20-29, F31, F42, F43.1, F60. * Participants with cognitive deficits assessed during the initial interview or diagnosis of ICD-10 F70-79. * Participants with planning or structured suicidal ideation. * Participants with difficulties in relational skills evaluated during the initial interview.

Contact & Investigator

Central Contact

Maria Traverso Rodriguez

✉ mariatraverso8@gmail.com

📞 +34 660512210

Frequently Asked Questions

Who can join the NCT06833567 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06833567 currently recruiting?

Yes, NCT06833567 is actively recruiting participants. Contact the research team at mariatraverso8@gmail.com for enrollment information.

Where is the NCT06833567 trial being conducted?

This trial is being conducted at Málaga, Spain.

Who is sponsoring the NCT06833567 clinical trial?

NCT06833567 is sponsored by Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology